AbbVie's R&D expenditures 2012-2018

This statistic illustrates the expenditure of AbbVie on research and development from 2012 to 2018. In 2018, AbbVie spent some 10.3 billion U.S. dollars on research and development. Abbot was a U.S.-based global pharmaceutical and healthcare products company, headquartered in Chicago, Illinois. In January 2013, Abbott was separated into two companies: Abbott Laboratories and AbbVie. Abbott Laboratories is now specialized on medical products, while AbbVie is responsible for research-based pharmaceuticals.

AbbVie's research and development spending from 2012 to 2018

R&D spending in million U.S. dollars
Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in

Release date

February 2019



Survey time period

2012 to 2018

Supplementary notes

* Research and development expenses in 2018 increased from 2017 principally due to a $5.1 billion intangible asset impairment charge related to IPR&D acquired as part of the 2016 Stemcentrx acquisition following the decision to stop enrollment in the TAHOE trial.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "AbbVie"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.